Wilmar Maarten Wiersinga
#147,567
Most Influential Person Across History
Wilmar Maarten Wiersinga's AcademicInfluence.com Rankings
Download Badge
Philosophy Biology
Wilmar Maarten Wiersinga's Degrees
- Doctorate Medicine University of Amsterdam
Why Is Wilmar Maarten Wiersinga Influential?
(Suggest an Edit or Addition)Wilmar Maarten Wiersinga's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. (2006) (2006)
- Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. (2011) (1884)
- Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy (1999) (970)
- Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy (1997) (803)
- The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy (2016) (687)
- Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. (2008) (659)
- Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. (1989) (539)
- Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. (2008) (388)
- Epidemiology and prevention of Graves' ophthalmopathy. (2002) (386)
- Smoking and risk of Graves' disease. (1993) (365)
- Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective. (2004) (329)
- Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. (1989) (321)
- Randomised double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy (1993) (311)
- Thyroid volume and urinary iodine in European schoolchildren: standardization of values for assessment of iodine deficiency. (1997) (307)
- The environment and autoimmune thyroid diseases. (2004) (302)
- Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy (2000) (293)
- Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. (2009) (278)
- 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism (2012) (275)
- Smoking and thyroid (2013) (274)
- Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. (1990) (272)
- Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy. (2012) (268)
- Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. (2005) (253)
- Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. (2014) (251)
- Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. (1991) (250)
- Selenium and the course of mild Graves' orbitopathy. (2011) (248)
- Development of a disease specific quality of life questionnaire for patients with Graves’ ophthalmopathy: the GO-QOL (1998) (247)
- Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. (2006) (246)
- Clinical features of dysthyroid optic neuropathy: a European Group on Graves’ Orbitopathy (EUGOGO) survey (2006) (242)
- Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. (1997) (232)
- Risk factors for and prevalence of thyroid disorders in a cross‐sectional study among healthy female relatives of patients with autoimmune thyroid disease (2003) (225)
- Is there a need to redefine the upper normal limit of TSH? (2006) (218)
- Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. (1990) (216)
- Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report. (2005) (201)
- The course of biochemical parameters of bone turnover during treatment with corticosteroids. (1991) (200)
- A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy. (2004) (199)
- Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience. (2003) (177)
- Association between serum interleukin-6 and serum 3,5,3'-triiodothyronine in nonthyroidal illness. (1993) (173)
- Fasting-induced changes in the hypothalamus-pituitary-thyroid axis. (2008) (172)
- Association of the TSHR gene with Graves' disease: the first disease specific locus (2005) (168)
- Glucocorticoids and Relapse of Major Depression (Dexamethasone/Corticotropin-Releasing Hormone Test in Relation to Relapse of Major Depression) (2006) (167)
- Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. (1995) (163)
- THE 2021 EUROPEAN GROUP ON GRAVES' ORBITOPATHY (EUGOGO) CLINICAL PRACTICE GUIDELINES FOR THE MEDICAL MANAGEMENT OF GRAVES' ORBITOPATHY. (2021) (163)
- Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. (2005) (162)
- Thyroid autoimmunity and miscarriage. (2004) (161)
- Thyroid peroxidase antibodies during gestation are a marker for subsequent depression postpartum. (2001) (158)
- A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. (2001) (158)
- Thyroid peroxidase autoantibodies in euthyroid subjects. (2005) (155)
- Initial thyroid status and cardiovascular risk factors: The EPIC‐Norfolk prospective population study (2010) (151)
- Thyroid Hormone Replacement Therapy (2002) (149)
- Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitre (1990) (149)
- Simultaneous changes in central and peripheral components of the hypothalamus-pituitary-thyroid axis in lipopolysaccharide-induced acute illness in mice. (2004) (148)
- Outcome of orbital decompression for disfiguring proptosis in patients with Graves’ orbitopathy using various surgical procedures (2008) (140)
- Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study. (2004) (136)
- Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus. (2005) (136)
- Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. (1990) (134)
- Vitamin D deficiency is not associated with early stages of thyroid autoimmunity. (2012) (132)
- Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease. (2009) (129)
- Temporal relationship between onset of Graves’ ophthalmopathy and onset of thyroidal Graves’ disease (1988) (127)
- Decreased nocturnal surge of thyrotropin in nonthyroidal illness. (1990) (126)
- A new and validated CT-based method for the calculation of orbital soft tissue volumes. (2008) (126)
- Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression (2006) (123)
- Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy. (2007) (119)
- Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors? (2011) (118)
- Orbital decompression for Graves' ophthalmopathy by inferomedial, by inferomedial plus lateral, and by coronal approach. (1990) (118)
- Predicting the Risk of Recurrence Before the Start of Antithyroid Drug Therapy in Patients With Graves' Hyperthyroidism. (2016) (117)
- Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice. (2004) (115)
- Induction of type 3 deiodinase activity in inflammatory cells of mice with chronic local inflammation. (2005) (113)
- Long-term effects of Graves' ophthalmopathy on health-related quality of life. (2002) (112)
- Management of the nontoxic multinodular goitre: A European questionnaire study (2000) (112)
- Thyroid and adrenal axis in major depression: a controlled study in outpatients. (2005) (111)
- Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial. (2018) (110)
- Current management of thyroid‐associated ophthalmopathy in Europe. Results of an international survey (1998) (109)
- Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy. (2004) (107)
- The influence of beta-adrenoceptor blocking agents on plasma thyroxine and triiodothyronine. (1977) (106)
- Clinical presentation of Graves' ophthalmopathy. (1989) (105)
- Induced illness in interleukin-6 (IL-6) knock-out mice: a causal role of IL-6 in the development of the low 3,5,3'-triiodothyronine syndrome. (1996) (101)
- Polymorphisms in the brain‐specific thyroid hormone transporter OATP1C1 are associated with fatigue and depression in hypothyroid patients (2008) (100)
- Hypothalamic thyroid hormone feedback in health and disease. (2006) (98)
- Clinical Relevance of Environmental Factors in the Pathogenesis of Autoimmune Thyroid Disease (2016) (97)
- ETA Guidelines : The Use of LT 4 + LT 3 in the Treatment of Hypothyroidism (2012) (97)
- The removal of the deep lateral wall in orbital decompression: its contribution to exophthalmos reduction and influence on consecutive diplopia. (2005) (97)
- Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3'-triiodothyronine therapy. (2005) (97)
- Subclinical hypothyroidism and hyperthyroidism. I. Prevalence and clinical relevance. (1995) (96)
- A survey of iodine intake and thyroid volume in Dutch schoolchildren: reference values in an iodine-sufficient area and the effect of puberty. (2001) (94)
- Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement (2017) (92)
- Quality of life in Graves' ophthalmopathy. (2012) (91)
- Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy. (2017) (91)
- Natural history of the transition from euthyroidism to overt autoimmune hypo- or hyperthyroidism: a prospective study. (2011) (90)
- Childhood Graves' ophthalmopathy: results of a European questionnaire study. (2005) (89)
- Pulsatile secretion of thyrotropin during fasting: a decrease of thyrotropin pulse amplitude. (1990) (87)
- Glucocorticoids decrease thyrotropin-releasing hormone messenger ribonucleic acid expression in the paraventricular nucleus of the human hypothalamus. (2005) (87)
- Ultra short-loop feedback control of thyrotropin secretion. (2004) (86)
- Diagnosis and management of amiodarone‐induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association (2004) (85)
- Increased oxidizability of low-density lipoproteins in hypothyroidism. (1998) (83)
- A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. (2006) (83)
- Effects of Graves’ ophthalmopathy on quality of life (2004) (82)
- Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism (2014) (82)
- Smoking and Risk of Gravesʼ Disease (1993) (81)
- Discontinuation of smoking increases the risk for developing thyroid peroxidase antibodies and/or thyroglobulin antibodies: a prospective study. (2009) (81)
- Lean body mass as a determinant of thyroid size (1998) (79)
- Prevalence of autoimmune thyroid dysfunction in postpartum psychosis (2011) (78)
- Ethnic differences in TSH but not in free T4 concentrations or TPO antibodies during pregnancy (2007) (78)
- Endocrine factors related to changes in total peripheral vascular resistance after treatment of thyrotoxic and hypothyroid patients. (2001) (77)
- Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes. (2000) (77)
- Pathogenesis of Graves' ophthalmopathy--current understanding. (2001) (76)
- Graves' Orbitopathy: A Multidisciplinary Approach - Questions and Answers (2010) (75)
- Diagnosis and management of amiodarone‐induced thyrotoxicosis: similarities and differences between North American and European thyroidologists * (2008) (75)
- Smoking and autoimmune thyroid disease: the plot thickens. (2006) (75)
- Graves’ ophthalmopathy: a rational approach to treatment (2002) (74)
- Frequency and characteristics of TBII‐seronegative patients in a population with untreated Graves’ hyperthyroidism: a prospective study (2008) (74)
- Preventing Graves' ophthalmopathy. (1998) (73)
- The hypothalamic-pituitary-thyroid axis in critical illness. (2001) (73)
- Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy. (1995) (73)
- Graves' orbitopathy : a multidisciplinary approach (2007) (73)
- Cushing’s syndrome complicated by multiple opportunistic infections (1998) (72)
- Amelioration of eye changes of Graves' ophthalmopathy by achieving euthyroidism (1989) (71)
- PREGO (presentation of Graves’ orbitopathy) study: changes in referral patterns to European Group On Graves’ Orbitopathy (EUGOGO) centres over the period from 2000 to 2012 (2015) (71)
- A questionnaire survey on the management of Graves' orbitopathy in Europe. (2006) (71)
- Prediction of progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score. (2008) (71)
- Do subtypes of graves' orbitopathy exist? (2011) (69)
- Thyrotoxicosis as a predisposing factor for cerebral venous thrombosis. (2000) (66)
- Distribution of thyrotropin‐releasing hormone (TRH)‐containing cells and fibers in the human hypothalamus (1994) (66)
- Reduction in goiter size by 131I therapy in patients with non-toxic multinodular goiter. (1995) (65)
- Soluble cytokine receptors and the low 3,5,3'-triiodothyronine syndrome in patients with nonthyroidal disease. (1995) (64)
- Reactivation of Graves' orbitopathy after rehabilitative orbital decompression. (2007) (63)
- Chronic local inflammation in mice results in decreased TRH and type 3 deiodinase mRNA expression in the hypothalamic paraventricular nucleus independently of diminished food intake. (2006) (63)
- Amiodarone and thyroid. (2009) (61)
- Triiodothyronine addition to paroxetine in the treatment of major depressive disorder. (2004) (61)
- Novel neuroanatomical pathways for thyroid hormone action in the human anterior pituitary. (2006) (61)
- Type 3 deiodinase is highly expressed in infiltrating neutrophilic granulocytes in response to acute bacterial infection. (2008) (61)
- Thyroid hormones modulate serum leptin levels: observations in thyrotoxic and hypothyroid women. (1998) (61)
- Management of Graves' ophthalmopathy (2007) (59)
- Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial. (2012) (57)
- A New Ultrasonographic Method to Detect Disease Activity and Predict Response to immunosuppressive Treatment in Graves Ophthalmopathy (1993) (57)
- Clinical recovery owing to target parietal cell failure in a patient with Zollinger-Ellison syndrome. (1977) (57)
- Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies (2014) (56)
- Extraocular muscle surgery for Graves' ophthalmopathy: does prior treatment influence surgical outcome? (1990) (56)
- Circulating IgGs may modulate IGF-I receptor stimulating activity in a subset of patients with Graves' ophthalmopathy. (2013) (56)
- Outcome of very long-term treatment with antithyroid drugs in Graves' hyperthyroidism associated with Graves' orbitopathy. (2011) (55)
- Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters (2000) (54)
- Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves’ orbitopathy? (2017) (53)
- Early versus late orbital decompression in Graves' orbitopathy: a retrospective study in 125 patients. (2006) (53)
- THE LONG‐TERM OUTCOME OF THYROIDECTOMY FOR SPORADIC NON‐TOXIC GOITRE (1989) (52)
- Thyroid hormone receptor expression in the human hypothalamus and anterior pituitary. (2005) (52)
- Thyroid dysfunction during pregnancy and in the first postpartum year in women with diabetes mellitus type 1. (2002) (51)
- Antithyroid drug treatment for Graves’ disease: baseline predictive models of relapse after treatment for a patient-tailored management (2018) (49)
- TRβ1 Protein Is Preferentially Expressed in the Pericentral Zone of Rat Liver and Exhibits Marked Diurnal Variation. (2002) (49)
- Age and gender-specific reference values of orbital fat and muscle volumes in Caucasians (2009) (48)
- Involvement of stress in the pathogenesis of autoimmune thyroid disease: A prospective study (2012) (48)
- Propranolol and thyroid hormone metabolism. (1991) (46)
- Differential Involvement of Orbital Fat and Extraocular Muscles in Graves' Ophthalmopathy (2013) (46)
- Amiodarone and thyroid hormone metabolism. (1986) (46)
- An evidence-based approach to the treatment of Graves' ophthalmopathy. (2000) (45)
- Measuring Eye Movements in Graves Ophthalmopathy (1994) (45)
- Two cases of amiodarone-induced thyrotoxicosis successfully treated with a short course of antithyroid drugs while amiodarone was continued. (1994) (45)
- Thyroid hormone metabolism in nonthyroidal illness (1996) (45)
- Skeletal muscle deiodinase type 2 regulation during illness in mice. (2009) (45)
- Thyrotropin-releasing hormone gene expression in the human hypothalamus (1996) (44)
- Management of thyroid nodules in children and adolescents. (2007) (44)
- The Neurologic Development of the Newborn and Young Child in Relation to Maternal Thyroid Function (1999) (44)
- Differential involvement of nuclear factor-kappaB and activator protein-1 pathways in the interleukin-1beta-mediated decrease of deiodinase type 1 and thyroid hormone receptor beta1 mRNA. (2006) (44)
- Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways. (2011) (44)
- Ultrasonographic versus scintigraphic measurement of thyroid volume in patients referred for 131I therapy. (1998) (44)
- Do we need still more trials on T4 and T3 combination therapy in hypothyroidism? (2009) (43)
- Classification of the eye changes of Graves' disease. (1991) (42)
- The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy (2001) (42)
- The effects of sex-steroid administration on the pituitary-thyroid axis in transsexuals. (2006) (41)
- Medical management of Graves' ophthalmopathy. (1995) (41)
- Differential effects of leptin and refeeding on the fasting-induced decrease of pituitary type 2 deiodinase and thyroid hormone receptor beta2 mRNA expression in mice. (2006) (40)
- Predictive score for the development or progression of Graves' orbitopathy in patients with newly diagnosed Graves' hyperthyroidism. (2018) (40)
- Anti‐heat shock protein (hsp)72 antibodies are present in patients with Graves' disease (GD) and in smoking control subjects (1997) (40)
- Pulsatile thyrotropin secretion in nonthyroidal illness. (1993) (40)
- Guidance in Subclinical Hyperthyroidism and Subclinical Hypothyroidism: Are We Making Progress? (2015) (40)
- Inhibition of T3-receptor binding by Nitrofen. (1994) (40)
- VEGF Levels in Plasma in Relation to Platelet Activation, Glycemic Control, and Microvascular Complications in Type 1 Diabetes (2013) (39)
- Graves' Disease: Can It Be Cured? (2019) (38)
- Management of amiodarone‐induced thyrotoxicosis in Latin America: an electronic survey (2006) (38)
- Decreased thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus of patients with major depression (2003) (37)
- Interleukin-18, a proinflammatory cytokine, contributes to the pathogenesis of non-thyroidal illness mainly via the central part of the hypothalamus-pituitary-thyroid axis. (2004) (37)
- Complete inhibition of rhTSH-, Graves' disease IgG-, and M22-induced cAMP production in differentiated orbital fibroblasts by a low-molecular-weight TSHR antagonist. (2012) (36)
- Establishment of reference values for endocrine tests. Part IV: Adrenal insufficiency. (2005) (36)
- Measuring eye movements in Graves ophthalmopathy. (1995) (36)
- Effect of smoking on orbital fat and muscle volume in Graves' orbitopathy. (2011) (36)
- Densities of Orbital Fat and Extraocular Muscles in Graves Orbitopathy Patients and Controls (2011) (36)
- Hypothyroid-like regulation of the pituitary-thyroid axis in stable human immunodeficiency virus infection. (1993) (35)
- Immunoneutralization of interleukin-1, tumor necrosis factor, interleukin-6 or interferon does not prevent the LPS-induced sick euthyroid syndrome in mice. (1997) (35)
- Circadian changes in pulsatile TSH release in primary hypothyroidism (1992) (34)
- Smoking and disease severity are independent determinants of serum adhesion molecule levels in Graves’ ophthalmopathy (2002) (34)
- Age and stress as determinants of the severity of hyperthyroidism caused by Graves' disease in newly diagnosed patients. (2008) (33)
- Uninhibited thyroidal uptake of radioiodine despite iodine excess in amiodarone-induced hypothyroidism. (1986) (32)
- The Amsterdam Declaration on Graves' orbitopathy. (2010) (32)
- Suppression of serum TSH by Graves' Ig: evidence for a functional pituitary TSH receptor. (2001) (32)
- Contribution of interleukin-12 to the pathogenesis of non-thyroidal illness. (2004) (32)
- Some studies on the natural history of Graves' orbitopathy: increase in orbital fat is a rather late phenomenon. (2015) (32)
- Thyroid hormone receptor {alpha} modulates lipopolysaccharide-induced changes in peripheral thyroid hormone metabolism. (2010) (32)
- Amiodarone reduces the effect of T3 on beta adrenergic receptor density in rat heart. (1990) (32)
- Establishment of reference values for endocrine tests. II: Hyperprolactinemia. (1999) (31)
- The nocturnal thyroid-stimulating hormone surge is absent in overt, present in mild primary and equivocal in central hypothyroidism. (1992) (31)
- THERAPY OF ENDOCRINE DISEASE: T4 + T3 combination therapy: is there a true effect? (2017) (31)
- Stress is not associated with thyroid peroxidase autoantibodies in euthyroid women (2005) (31)
- Propranolol inhibits the in vitro conversion of thyroxine into triiodothyronine by isolated rat liver parenchymal cells. (1979) (30)
- Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients. (2010) (30)
- A new ultrasonographic method to detect disease activity and predict response to immunosuppressive treatment in Graves ophthalmopathy. (1994) (30)
- Comparison of beclomethasone dipropionate (2 and 3 mg) and prednisolone sodium phosphate enemas (30 mg) in the treatment of ulcerative proctitis. An adrenocortical approach. (1989) (30)
- Relationship between serum 3,5,3′-triiodothyronine and serum interleukin-8, interleukin-10 or interferonγ in patients with nonthyroidal illness (1996) (30)
- Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients. (2003) (29)
- Thyroid hormone receptor isoform expression in livers of critically ill patients. (2007) (29)
- Is repeated fine-needle aspiration cytology indicated in (benign) thyroid nodules? (1995) (29)
- Orbital radiotherapy for Graves’ ophthalmopathy: Useful or useless? Safe or dangerous? (2003) (29)
- Should we treat mild subclinical/mild hyperthyroidism? Yes. (2011) (28)
- Pulsatile thyrotropin secretion in patients with Cushing's syndrome. (1994) (28)
- Probable risk of tumor induction after retro-orbital irradiation for Graves' ophthalmopathy. (1996) (28)
- Studies on the mechanism of inhibition of nuclear triiodothyronine binding by fatty acids (1989) (28)
- Soluble IL‐2 receptor levels in patients with Graves’ophthalmopathy (1992) (28)
- Lacking thyroid hormone receptor beta gene does not influence alterations in peripheral thyroid hormone metabolism during acute illness. (2008) (28)
- Immunosuppressive treatment of Graves' ophthalmopathy (1990) (27)
- Octreotide scintigraphy in thyroidal and orbital Graves' disease. (1998) (26)
- Interleukin-1β modulates endogenous thyroid hormone receptor α gene transcription in liver cells (2007) (26)
- Effect of prednisone on renal function in man. (1993) (25)
- Facial disfigurement: is it in the eye of the beholder? A study in patients with Graves’ ophthalmopathy (2003) (25)
- Establishment of reference values for endocrine tests. I: Cushing's syndrome. (1998) (25)
- Therapeutic controversies. Retrobulbar radiation in Graves' ophthalmopathy. (1995) (25)
- Evaluation of endocrine tests. D: the prolonged fasting test for insulinoma. (2009) (25)
- Immunomodulatory treatment of Graves' ophthalmopathy. (1998) (25)
- Thyrotropin, but not a polymorphism in type II deiodinase, predicts response to paroxetine in major depression. (2006) (24)
- A thyrotropin-secreting pituitary adenoma as a cause of thyrotoxic periodic paralysis (1998) (24)
- Graves′ orbitopathy: Management of difficult cases (2012) (24)
- Editorial: Pathogenesis of Graves' ophthalmopathy - current understanding (2001) (23)
- Thyroid disease symptoms during early pregnancy do not identify women with thyroid hypofunction that should be treated (2017) (23)
- Recent Developments in Graves’ Ophthalmopathy (2000) (23)
- Perspective--Part III: retrobulbar irradiation in Graves orbitopathy: the Dutch experience. (2002) (23)
- Advances in medical therapy of thyroid-associated ophthalmopathy (1996) (23)
- The effect of long-term prednisone treatment on growth hormone and insulin-like growth factor-I (1996) (22)
- Autoimmune thyroid disease : old and new players (2014) (22)
- Myxedema and Coma (Severe Hypothyroidism) (2015) (22)
- Alcohol Consumption as a Risk Factor for Autoimmune Thyroid Disease: A Prospective Study (2012) (22)
- The influence of previous orbital irradiation on the outcome of rehabilitative decompression surgery in graves orbitopathy. (2008) (22)
- TR(beta)1 protein is preferentially expressed in the pericentral zone of rat liver and exhibits marked diurnal variation. (2002) (22)
- Graves' ophthalmopathy through the eyes of the patient: A state of the art on health-related quality of life assessment (2001) (22)
- Immunosuppressive treatment of Graves' ophthalmopathy. (1990) (22)
- T4 + T3 combination therapy: any progress? (2019) (22)
- Amiodarone inhibits thyroidal iodide transport in vitro by a cyclic adenosine 5'-monophosphate- and iodine-independent mechanism. (2006) (21)
- Pulsatile thyrotropin release in patients with untreated pituitary disease. (1993) (21)
- Decreased neuropeptide Y (NPY) expression in the infundibular nucleus of patients with nonthyroidal illness (2001) (21)
- The use of colour slides in the assessment of changes in soft-tissue involvement in Graves’ ophthalmopathy (1998) (20)
- Transient hypothyroxinemia in juvenile glycoprotein hormone subunit B5 knock-out mice (2010) (20)
- The role of thyroid hormone nuclear receptors in the heart: evidence from pharmacological approaches (2008) (20)
- Tissue distribution of amiodarone and desethylamiodarone in rats after multiple intraperitoneal administration of various amiodarone dosages. (1985) (20)
- Radiation and Graves' ophthalmopathy (1995) (19)
- An increase in plasma cholesterol independent of thyroid function during long-term amiodarone therapy. A dose-dependent relationship. (1991) (19)
- Nonthyroidal illness [ch. 11D] (2005) (19)
- Proposal of success criteria for strabismus surgery in patients with Graves' orbitopathy based on a systematic literature review (2015) (18)
- PGC-1α regulates the isoform mRNA ratio of the alternatively spliced thyroid hormone receptor α transcript (2006) (18)
- The attitude toward hypothyroidism during early gestation: time for a change of mind? (2014) (18)
- Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after intravenous administration. (1989) (18)
- Physiological and pathophysiological aspects of thyrotropin-releasing hormone gene expression in the human hypothalamus. (1998) (18)
- Tissue distribution of amiodarone and desethylamiodarone in rats after repeated oral administration of various amiodarone dosages. (1985) (17)
- Action of specific thyroid hormone receptor α(1) and β(1) antagonists in the central and peripheral regulation of thyroid hormone metabolism in the rat. (2012) (17)
- The Philosophy of Graves' Ophthalmopathy (2005) (17)
- Evaluation of endocrine tests. B: screening for hypercortisolism. (2005) (17)
- Expression of the alpha 1, alpha 2, and beta 1 T3-receptor mRNAs in the fasted rat measured using competitive PCR. (1998) (17)
- Establishment of reference values for endocrine tests--part V: acromegaly. (2006) (17)
- Establishment of reference values for endocrine tests. III: Primary aldosteronism. (2003) (17)
- Proposal for Standardization of Primary and Secondary Outcomes in Patients with Active, Moderate-to-Severe Graves’ Orbitopathy (2020) (17)
- Towards an animal model of amiodarone-induced thyroid dysfunction. (1997) (16)
- Inhibition of nuclear T3 binding by fatty acids: dependence on chain length, unsaturated bonds, cis-trans configuration and esterification. (1990) (16)
- Competitive inhibition of T3 binding to α1 and β1 thyroid hormone receptors by fatty acids (1991) (16)
- Thyroid autoimmunity. (2014) (16)
- Establishment of reference values for endocrine tests. Part VII: growth hormone deficiency. (2009) (15)
- The relation between gastrin, gastric acid and thyroid function disorders. (1980) (15)
- Changes in serum adhesion molecules, chemokines, cytokines, and tissue remodeling factors in euthyroid women without thyroid antibodies who are at risk for autoimmune thyroid disease: a hypothesis on the early phases of the endocrine autoimmune reaction. (2013) (15)
- Immunoradiometric assay of thyrotropin in plasma: its value in predicting response to thyroliberin stimulation and assessing thyroid function in amiodarone-treated patients. (1986) (15)
- The Pro12Ala PPARγ gene polymorphism: possible modifier of the activity and severity of thyroid‐associated orbitopathy (TAO) (2009) (15)
- The future endocrine patient. Reflections on the future of clinical endocrinology. (2003) (14)
- Interleukin-1beta modulates endogenous thyroid hormone receptor alpha gene transcription in liver cells. (2007) (14)
- Traumatic Neuroma of the Infraorbital Nerve Subsequent to Inferomedial Orbital Decompression for Graves’ Orbitopathy (2010) (14)
- Combined thyroid eye clinic: the importance of a multidisciplinary health care in patients with Graves' orbitopathy. (2010) (14)
- Selective macrophage depletion in the liver does not prevent the development of the sick euthyroid syndrome in the mouse. (1996) (14)
- Relation between lean body mass and thyroid volume in competition rowers before and during intensive physical training. (2001) (14)
- Genotypes in relation to phenotypic appearance and exposure to environmental factors in Graves' hyperthyroidism. (2012) (13)
- What Is the Aim of Immunosuppressive Treatment in Patients With Graves’ Orbitopathy? (2014) (13)
- Thyroid associated ophthalmopathy: pediatric and endocrine aspects. (2004) (13)
- Impact of month of birth on the development of autoimmune thyroid disease in the United Kingdom and Europe. (2014) (13)
- ASSOCIATION BETWEEN AUTOIMMUNE THYROID DISEASE, ATOPY, AND URTICARIA? (1984) (13)
- Variation in phenotypic appearance of Graves' disease: effect of genetic anticipation and duration of complaints. (2009) (13)
- Comparison of Cyclodeviation and Duction Measurement in Graves’ Orbitopathy Patients Using Different Devices (2011) (12)
- Pulsatile thyrotropin and prolactin secretion in a patient with a mixed thyrotropin- and prolactin-secreting pituitary adenoma. (1994) (12)
- Treatment of amiodarone-induced hypothyroidism with potassium perchlorate. (1993) (12)
- Environmental factors in autoimmune thyroid disease. (2009) (12)
- Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after oral administration. (1987) (12)
- Longitudinal Trajectories of Gestational Thyroid Function: A New Approach to Better Understand Changes in Thyroid Function (2018) (12)
- Thyroid eye disease: current concepts and the EUGOGO perspective (2005) (12)
- Hypermetabolism in Gaucher disease type I is not associated with altered thyroid hormone levels (2007) (11)
- Thyrostimulin deficiency does not alter peripheral responses to acute inflammation-induced nonthyroidal illness. (2014) (11)
- Assessment of disease activity of Graves’ ophthalmopathy (2000) (11)
- HLA-DR4 associated response to corticosteroids in Graves’ ophthalmopathy patients (1990) (11)
- Evaluation of Endocrine Tests. C: glucagon and clonidine test in phaeochromocytoma. (2009) (11)
- Contributions of cytokines to nonthyroidal illness (2006) (11)
- Graves' dermopathy: does octreotide scintigraphy predict the response to octreotide treatment? (1996) (11)
- Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy. (2004) (11)
- Differential involvement of nuclear factor- (cid:1) B and activator protein-1 pathways in the interleukin-1 (cid:2) -mediated decrease of deiodinase type 1 and thyroid hormone receptor (cid:2) 1 mRNA (2006) (10)
- Assessment of disease severity (2000) (10)
- Glucocorticoid administration for Graves' hyperthyroidism treated by radioiodine. A questionnaire survey among members of the European Thyroid Association. (2010) (10)
- Orphenadrine (Disipal), serum thyroxine and thyroid function. (1977) (10)
- The effect of alpha- and beta-adrenoceptor agonists and antagonists on the in vitro conversion of thyroxine into triiodothyronine. (1980) (10)
- COMPLETE REMISSION OF AUTOIMMUNE THROMBOCYTOPENIA AFTER EXTIRPATION OF A BENIGN ADENOFIBROMA OF THE OVARY (1990) (10)
- Nonthyroidal Illness Syndrome (2013) (9)
- Prevalence of growth hormone deficiency in Hashimoto's thyroiditis. (2010) (9)
- Circulating monocyte migration inhibitory factor in serum of Graves' ophthalmopathy patients: a parameter for disease activity? (1989) (9)
- The effect of long-term prednisone treatment on growth hormone and insulin-like growth factor-1. (1996) (9)
- Is sleeping position related to asymmetry in bilateral Graves' ophthalmopathy? (2008) (9)
- Natural Course of Mild Graves Orbitopathy: Increase of Orbital Fat But Decrease of Muscle Volume With Increased Muscle Fatty Degeneration During a 4-Year Follow-Up. (2019) (8)
- Combined Thyroid-Eye Clinics (2007) (8)
- Aberrant Levels of Hematopoietic/Neuronal Growth and Differentiation Factors in Euthyroid Women at Risk for Autoimmune Thyroid Disease (2016) (8)
- IgA class thyroid peroxidase and thyroglobulin autoantibodies in Graves' disease: association with the male sex. (1993) (8)
- Thyrotropin receptor autoantibodies recognizing two different epitopes on the TSH receptor: lack of relationship to patient age, sex, and ophthalmopathy. (1993) (8)
- Antithyroid drugs in Graves’ hyperthyroidism: differences between “block and replace” and “titration” regimes in frequency of euthyroidism and Graves’ orbitopathy during treatment (2020) (8)
- Amplification by polymerase chain reaction of immunoglobulin heavy and light chain genes from orbital tissue of patients with Graves' ophthalmopathy. (1993) (8)
- Future Research in Graves' Orbitopathy: From Priority Setting to Trial Design Through Patient and Public Involvement. (2015) (7)
- Immunosuppression of Graves' hyperthyroidism--still an elusive goal. (1996) (7)
- Maternal cognitive function during pregnancy in relation to hypo‐ and hyperthyroxinemia (2019) (7)
- Chronic infection with Yersinia enterocolitica in patients with clinical or latent hyperthyroidism. (2003) (7)
- Evaluation of endocrine tests. A: the TRH test in patients with hyperprolactinaemia. (2003) (7)
- Determinants of outcome in sporadic nontoxic goiter. (1992) (6)
- Hypothyroidism and Myxedema Coma (2015) (6)
- Amiodarone induces a dose-dependent increase of plasma cholesterol in the rat. (1991) (6)
- Graves' orbitopathy in a patient with adrenoleukodystrophy after bone marrow transplantation. (2009) (6)
- Thyroid cancer in children and adolescents--consequences in later life. (2001) (6)
- Energy Homeostasis and Body Weight before and after Cessation of Block and Replacement Therapy in Euthyroid Patients with Graves' Disease (2011) (6)
- Five-year cimetidine maintenance trial for peptic ulcer disease. A clinical and endocrinologic approach. (1990) (6)
- Environmental factors in healthy woman at risk for autoimmune thyroid disease (2000) (6)
- Goserelin-induced transient thyrotoxicosis in a hypothyroid woman on L-thyroxine replacement. (2008) (6)
- Supernumerary extraocular muscle in Graves' orbitopathy. (2007) (6)
- Graves' quality of life. (2007) (6)
- Unilateral Graves’ orbitopathy: a case control and retrospective follow up study. (2004) (5)
- Triiodothyronine (T3)-autoantibodies in two goitrous patients. (1982) (5)
- Hypothyroidism, Causes of (2004) (5)
- Competitive inhibition of T3 binding to alpha 1 and beta 1 thyroid hormone receptors by fatty acids. (1991) (5)
- [The interpretation of the thyroid stimulating hormone (TSH) assay]. (2003) (5)
- Autoimmune thyroid diseases (2002) (5)
- Reactivation of Graves’ orbitopathy after aesthetic orbital decompression. (2004) (4)
- Immunosuppression in endocrine ophthalmopathy: why and when? (1993) (4)
- Inhibition of nuclear T3 binding via PLA2-induced release of fatty acids from nuclear membranes. (1990) (4)
- Immunosuppressive management of Graves’ ophthalmopathy (2000) (4)
- [Diagnosis of hyper- and hypothyroidism in patients using amiodarone]. (1983) (4)
- Therapy: Evidence-based treatment of Graves ophthalmopathy (2009) (4)
- Glucocorticoid administration for Graves’ hyperthyroidism treated by radioiodine. A questionnaire survey among members of the European Thyroid Association (2010) (4)
- Pharmacological Effects of Amiodarone and Dronedarone on Cardiac Thyroid Hormone Receptors (2009) (4)
- Genetic and Environmental Contributions to Pathogenesis (2001) (4)
- PLA2 activity in rat liver nuclei. (1993) (3)
- Clinical criteria fortheassessment ofdisease activity in Graves' ophthalmopathy: anovelapproach (1989) (3)
- Conceptual evolution in the relationship between Graves' ophthalmopathy and thyroidal Graves' disease (1984) (3)
- The application of an immunoradiometric assay of plasma thyrotropin (TSH-IRMA) in molar pregnancy (1988) (3)
- [Pain in the throat due to acute suppurative thyroiditis caused by Salmonella]. (2008) (3)
- Response to Rosario (2012) (3)
- Modulation of gastrin release by acute changes in plasma calcium. (1978) (3)
- [Screening pregnant women for hypothyroidism: as yet only in high risk groups]. (2003) (3)
- Interaction between nuclear hormone receptors and coactivators analyzed using a nonradioactive "Pull-Down" assay. (1999) (3)
- Introduction to Graves’ ophthalmopathy (2000) (2)
- Combined Thyroid–Eye Clinics in the Management of Graves’ Ophthalmopathy (2015) (2)
- Induction models of autoimmune thyroid disease--critical comments. (2009) (2)
- Inhibition of nuclear T3 binding by fatty acids liberated from nuclear membranes via phospholipase C. (1991) (2)
- Re: "Computer-aided analysis of orbital volume: a novel technique". (2014) (2)
- Hypothyroidism, Diagnosis of (2004) (2)
- Smoking a risk factor for hypothyroidism [correction of hyperthyroidism]. (1993) (2)
- [Timely recognition and treatment of hypothyroidism in pregnant women: benefit for the child]. (2001) (2)
- Increased uptake of technetium-99m HDP in the subcortical area of both femurs in a patient with Graves' disease. (2007) (2)
- [Subclinical hypothyroidism; the start of a clinical trial into the usefulness of treatment with radioactive iodine]. (2004) (2)
- Thyroid Gland, Anatomy and Physiology (2004) (2)
- [Subclinical functional disorders of the thyroid gland]. (2003) (2)
- [Pregnancy (conception) in hyper- or hypothyroidism]. (2001) (2)
- The large eyes of Wolfgang Amadeus Mozart (2007) (2)
- Smoking a risk factor for hyperthyroidism (1993) (2)
- [Cardiovascular risks in patients with subclinical thyroid dysfunction]. (2012) (1)
- Early stages of thyroid autoimmunity (2009) (1)
- [Experience with the thyrotropin releasing hormone (TRH) test in the diagnosis of Graves' ophthalmopathy]. (1982) (1)
- Differentiated Thyroid Carcinoma in Pediatric Age (2007) (1)
- Pulsatile hormone secretion: Analysis and biological significance (1995) (1)
- Frequet Miscarriages - Is TPO, the possible culprit? (2006) (1)
- Thyroid function: Quitting smoking—transient risk of autoimmune hypothyroidism (2012) (1)
- Hypothyroid symptoms throughout pregnancy are predominantly associated with thyroxine and not with thyrotropin concentrations. (2022) (1)
- The European Thyroid Journal in Its Third Year of Publication: A Thriving Enterprise (2014) (1)
- Selenium and pentoxifylline in patients with mild Graves' orbitopathy: Results of a randomized placebo-controlled double-blind clinical trial (2010) (1)
- TSH: is there a need to redefine the Normal range? (2005) (1)
- L-T4 and L-T3 combined treatment vs L-T4 alone. (2007) (1)
- Smoking and prevention of thyroid eye disease (2015) (1)
- Graves' ophthalmopathy (GO) (2011) (1)
- The large eyes of Wolfgang Amadeus Mozart. (On the occasion of the 250th Mozart anniversary year). (2005) (1)
- The 7th Year of Uninterrupted Publication of the European Thyroid Journal (2017) (1)
- [The practice guideline 'Thyroid disorders' (first revision) from the Dutch College of General Practitioners; a response from the perspective of internal medicine]. (2007) (1)
- The effect of iodine-containing contrast media on the thyroid (2005) (1)
- Recommendations for the assessment of Therapeutic Outcome of Graves’ ophthalmopathy in clinical trials (2000) (1)
- Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis. (2023) (1)
- Future Research in Graves’ ophthalmopathy (2000) (1)
- [Uncertainties about the benefit of treatment in subclinical thyroid dysfunction]. (2006) (1)
- The value of sensitive TSH measurements in clinical practice. (1986) (1)
- Author's response: medical or surgical decompression of optic neuropathy in Graves’ ophthalmopathy: the choice remains unclear (2006) (1)
- Iodine-induced thyroid disease [ch. 17] (2002) (1)
- Vitamin D deficiency is not associated with thyroid autoimmunity (2012) (1)
- Management of Thyrotoxicosis Without Hyperthyroidism (2021) (1)
- Re: "thyroid eye disease presenting after cosmetic botulinum toxin injections". (2007) (1)
- Prediction and prevention of autoimmune thyroid disease (2004) (1)
- Graves' ophthalmopathy and dermopathy. Preface. (2012) (1)
- Front & Back Matter (2019) (0)
- Table 9-3, Causes of hypothyroidism (2014) (0)
- Table 9-1, Grades of hypothyroidism (2014) (0)
- Front & Back Matter (2019) (0)
- [Hypothyroidism following mantle irradiation for Hodgkin's disease]. (1983) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2018) (0)
- Graves' ophthalmopathy: problems solved and new questions to be answered (2008) (0)
- Table 9-10. I, ncidence of symptoms and signs in hypothyroidism (2014) (0)
- Treatment of amiodarone-induced thyrotoxicosis (AIT) type 2: a RCT (2010) (0)
- Front & Back Matter (2019) (0)
- Medullary thyroid carcinomain children (2006) (0)
- Front & Back Matter (2017) (0)
- Fraud in a pharmaceutical trial: letter (2000) (0)
- Thyroid function tests. I. Studies in euthyroid volunteers. (1980) (0)
- Front & Back Matter (2017) (0)
- Comprar Grave´s Orbitopathy 2Ed: A Multidisciplinary Approach | Wilmar M. Wiersinga | 9783805595315 | Karger AG (2010) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2018) (0)
- Front & Back Matter (2014) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2017) (0)
- Table 9-7, Manifestations of hypothyroidism in the musculoskeletal system. (2014) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2012) (0)
- [Value of the assay of plasma triiodothyronine level for the diagnosis of hyperthyroidism and hypothyroidism]. (1978) (0)
- Thyroid dysfunction induced by Amiodarone (focused on prevalence, predisposing factors, treatment) (2009) (0)
- Graves’ Orbitopathy and Dermopathy (2021) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2015) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2017) (0)
- Front & Back Matter (2017) (0)
- Front & Back Matter (2019) (0)
- Thyroidology in Europe (2004) (0)
- Front & Back Matter (2019) (0)
- [Table, 9.2.2. EPIDEMIOLOGY OF HYPOTHYROIDISM]. (2014) (0)
- Etiology of Graves ophthalmology (2002) (0)
- Table 9-8, Gastrointestinal manifestations of hypothyroidism. (2014) (0)
- Front & Back Matter (2016) (0)
- Association of the thyrotrophin receptor gene (TSHR) with Gravesapos disease: evidence from independent UK population based case control and family studies (2005) (0)
- Front & Back Matter (2018) (0)
- IgA CLASS THYROID PEROXIDASE AND THYROGLOBULIN ASSOCIATION WITH THE MALE SEX - AUTOANTIBODIES IN GRAVES' DISEASE: (1993) (0)
- Front & Back Matter (2019) (0)
- [Hot feelings about cold thyroid nodules]. (1989) (0)
- Figure 9-2, [Logit probability (log odds) for...]. (2014) (0)
- In Memoriam Professor Peter M. Laurberg (2016) (0)
- Contents Vol. 7, 2018 (2018) (0)
- Front & Back Matter (2012) (0)
- A New Kid on the Block: The European Thyroid Journal (2012) (0)
- Front & Back Matter (2020) (0)
- Iron Deficiency Anemia - Management in Different Clinical Settings (2019) (0)
- Orpenadrine (Disipal), serum thyroxine and thyroid function (1975) (0)
- European Thyroid Journal: Looking Backwards and Forwards (2021) (0)
- Yersina Enterocolitica infections and autoimmune thyroid diseases (2004) (0)
- Table 9-17. I, [ndications for screening for hypothyroidism. (Reproduced with permission) 8]. (2014) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2019) (0)
- psychosisof autoimmune thyroid dysfunction in postpartum (2011) (0)
- The rise of a submerged goiter. (2000) (0)
- Thyroid and pregnancy. (2009) (0)
- The role of octreotide in the management of Graves' ophthalmopathy (2002) (0)
- Front & Back Matter (2019) (0)
- Measuring Eye Movements in Gravesʼ Ophthalmology (1996) (0)
- Front & Back Matter (2017) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2019) (0)
- New Impact for the Journal (2019) (0)
- Table 9-12, Reversible causes of hypothyroidism (2014) (0)
- 3 3 Suppressio nn of Serum Thyrotropi n by Groves ' Immunoglobulins : : €videnc e for o Functiona l Pituitar yy Thyrotropi n Recepto r (2007) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2019) (0)
- The European Thyroid Journal Reaches Adulthood: Starting Its Fourth Year of Publication (2015) (0)
- Thyroid dysfunction is not linked with a significantly increased risk for coronary heart disease (2009) (0)
- Front & Back Matter (2019) (0)
- Does orbital radiotherapy influence the effect of orbital decompression in Graves’ orbitopathy. (2005) (0)
- Table 9-13, Conditions requiring adjustment of the replacement dose of thyroxine for hypothyroidism. (2014) (0)
- Contents Vol. 6, 2017 (2017) (0)
- Front & Back Matter (2019) (0)
- Worldwide Consensus on Thyroid Eye Disease? What Is In a Name? (2022) (0)
- Front & Back Matter (2019) (0)
- [Choice of time of surgery in the surgical rehabilitation of Graves' ophthalmopathy]. (1992) (0)
- Treatment of endocrine ophthalmopathy. (1999) (0)
- B-lymphocyte subset distribution and serum immuno-globulin levels in Graves' ophthalmopathy patients (1986) (0)
- [Radioactive iodine; a useful alternative in the treatment of non-toxic goiter?]. (1991) (0)
- Front & Back Matter (2018) (0)
- Front & Back Matter (2013) (0)
- Management of Graves’ orbitopathy in Europe: a questionnaire survey conducted by the European Group on Graves Orbitopathy (EU.GO.GO). (2006) (0)
- Front & Back Matter (2019) (0)
- Management of non-toxic multinodular goitre (2002) (0)
- Front & Back Matter (2019) (0)
- Table 9-9, Schematic approach of the patient suspected of hypothyroidism. (2014) (0)
- Front & Back Matter (2019) (0)
- [Subclinical hyperthyroidism: not necessarily a thyroid disorder]. (2003) (0)
- Front & Back Matter (2019) (0)
- Re: "clinical features and treatment of graves ophthalmopathy in pediatric patients". (2006) (0)
- Front & Back Matter (2018) (0)
- Front & Back Matter (2017) (0)
- Table 9-4, Changes in serum lipids in hypothyroidism (2014) (0)
- Front & Back Matter (2018) (0)
- Front & Back Matter (2019) (0)
- Thyroid hormone and depression (2000) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2019) (0)
- Figure 9-5, Flow-diagram for the biochemical diagnosis of hypothyroidism. (2014) (0)
- Quality of lilfe (2007) (0)
- Front & Back Matter (2019) (0)
- UvA-DARE ( Digital Academic Repository ) Development of a disease specific quality of life questionaire for patients with Graves ' ophthalmopathy : the GO-QOL (1998) (0)
- Thyroid management in Graves' ophthalmopathy (2000) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2019) (0)
- Monitoring activity of Graves' Ophthalmology (2005) (0)
- Front & Back Matter (2019) (0)
- Autoimmune thyroid disease (2013) (0)
- [Drugs in thyroid diseases]. (1986) (0)
- Chapter 11C: Nonthyroidal illnes syndrome (2012) (0)
- European Thyroid Journal Is Completing Its First Quinquennium (2016) (0)
- Front & Back Matter (2019) (0)
- T4+T3 Combination Therapy: An Unsolved Problem of Increasing Magnitude and Complexity (2021) (0)
- Mark F. Prummel, M.D. (1956 – 2005) (2005) (0)
- Front & Back Matter (2019) (0)
- Prevalence of growth hormone deficiency in autoimmune hypothyroidism (2009) (0)
- Table 9-16, Summary of data on subclinical hypothyroidism. (2014) (0)
- Front & Back Matter (2018) (0)
- Front & Back Matter (2019) (0)
- Table 9-11, Accuracy of 12 symptoms and signs in the diagnosis of primary hypothyroidism 122 . (2014) (0)
- ophthalmopathy: the GO-QOL questionnaire for patients with Graves' Development of a disease specific quality of life (1998) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2018) (0)
- The Relevance of the TRH-Test in the Differential Diagnosis of Exophthalmos (1978) (0)
- Table 9-15, Abnormalities reported in some but not all studies on subclinical hypothyroidism. (2014) (0)
- Nuclear thyroid hormone receptors. (1985) (0)
- Front & Back Matter (2019) (0)
- Figure 9-4, Assessment of hypothyroidism by a clinical score, composed of 12 symptoms and signs as listed in Table 3 (Reproduced with persmission(4)). (2014) (0)
- Front & Back Matter (2019) (0)
- Environmental influences on autoimmunity (2015) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2017) (0)
- Front & Back Matter (2019) (0)
- L-T 4 and LT 3 combined treatment vs LT 4 alone (2007) (0)
- M63 – Graves Ophthalmopathy (2013) (0)
- Figure 9-6, [Relationship between the optimal daily...]. (2014) (0)
- Front & Back Matter (2019) (0)
- The European Thyroid Journal Enters Its Second Year of Publication in Excellent Shape (2013) (0)
- Front & Back Matter (2018) (0)
- [Demand and supply in the laboratory diagnosis of thyroid gland function]. (1985) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2018) (0)
- [A case of fraud in a neurological pharmaceutical clinical trial]. (2003) (0)
- Thyroid volume and urinary iodine in Hungarian school children (2000) (0)
- Title Page / List of Contents / Preface to the Second, Revised Edition / Preface to the First Edition (2010) (0)
- Front & Back Matter (2013) (0)
- Thyroid and adrenal axes in major depression (2000) (0)
- Drugs and thyroid. Preface. (2009) (0)
- Table 9-14, Recommendations for the treatment of myxedema coma. (2014) (0)
- British Medical Journal (1874) (0)
- Front & Back Matter (2018) (0)
- Front & Back Matter (2019) (0)
- Table 9-6, Cardiovascular manifestations of hypothyroidism. (2014) (0)
- Front & Back Matter (2019) (0)
- Genome Technologies in Human Genetics (2019) (0)
- Somatostatin Receptor Scintigraphy in Thyroidal Diseases (2000) (0)
- Thyroid Cancer and the Endocrinologist (2006) (0)
- Front & Back Matter (2015) (0)
- [From gene to disease; thyroid stimulating hormone receptor, hyperthyroidism and hypothyroidism]. (2001) (0)
- Front & Back Matter (2019) (0)
- The European Thyroid Journal Reaches Its Sixth Year of Publication with Honours (2017) (0)
- [Drug treatment of Graves' ophthalmopathy]. (1990) (0)
- Graves' ophthalmology and dermopathy (2002) (0)
- Adult hypothyroidism [chapter 9] (1999) (0)
- Front & Back Matter (2019) (0)
- Thyroid function tests. II. Studies in patients with thyroid diseases. (1980) (0)
- Front & Back Matter (2019) (0)
- Front & Back Matter (2018) (0)
- Hashimoto's disease (2004) (0)
- UvA-DARE ( Digital Academic Repository ) Establishment of reference values for endocrine tests . III : primary (2003) (0)
- Front & Back Matter (2019) (0)
- [Determining the thyroid hormones T3 and T4 in the urine: an unreliable test for hypothyroidism]. (2007) (0)
- Front & Back Matter (2012) (0)
- Thyroid and sports: a connection marking the olympic games in athens 2004. (2005) (0)
- In Memoriam – Prof. Dr. Georg Hennemann, Internist (1932–2018) (2019) (0)
- Graves’ Disease (Thyrotoxicosis) (2007) (0)
- Front & Back Matter (2016) (0)
- Front & Back Matter (2018) (0)
- Front & Back Matter (2019) (0)
- Relationship between thyroid disorders and orbitopathy, including management factors (2005) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Wilmar Maarten Wiersinga?
Wilmar Maarten Wiersinga is affiliated with the following schools:
